๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral topotecan toxicities vary with length of dosing schedule

Book ID
120872760
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
1999
Weight
294 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase I study of sequential administra
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors
โœ Caio M. S. Rocha Lima; Carlo V. Catapano; Daniel Pacheco; Carol A. Sherman; Greg ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Based on preclinical findings and on the clinical antitumor efficacy of sequential paclitaxel/topotecan and topotecan/etoposide, the authors sought to define the maximum tolerated doses (MTDs) and doseโ€limiting toxicities (DLTs) associated with a sequential combination of

Treatment of myelodysplastic syndrome wi
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan : A Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803)
โœ David L. Grinblatt; Daohai Yu; Vera Hars; James W. Vardiman; Bayard L. Powell; S ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 156 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUD: The Cancer and Leukemia Group B evaluated oral topotecan administered at 2 schedules and doses for myelodysplastic syndrome (MDS). ## METHODS: Patients with previously untreated primary or therapyโ€related MDS were eligible. Patients with refractory anemia (RA), RA with

Developmental toxicity evaluation of rat
Developmental toxicity evaluation of rats dosed orally or cutaneously with octoxynol-9
โœ Hon-Wing Leung; Bryan Ballantyne ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB ๐Ÿ‘ 2 views

Pregnant CD ยฎ rats were dosed cutaneously (530, 1600 or 4270 mg kg ุŠ1 day ุŠ1 ) or fed diets containing octoxynol-9 (70 or 340 mg kg ุŠ1 day ุŠ1 ) during the major period of organogenesis. Monitors for maternal toxicity included clinical observations, body weight, organ weight and food consumption. Fet